The COVID-19 pandemic has surged in the Czech Republic and the Prime Minister has ordered stringent lockdowns. While this European nation of 10.7 million doesn’t have nearly enough vaccines, they are apparently embracing ivermectin, the drug already in use in multiple Eastern European nations. As TrialSite has reported, Slovakia, Macedonia, and Bulgaria have formally accepted the generic, FDA approved drug due to its ability to inhibit the novel coronavirus. Now in a recent entry in Czech Republic media the head cardiologist of a prominent hospital reports that a major shipment of the drug has arrived at his facility. Apparently, they have purchased 20,000 doses and will serve as some form of distribution hub for ivermectin. Lots of physicians in other hospitals are calling and requesting the drug. In an interview, the head of the Internal Cardiology Clinic at the University Hospital of St. Peter’s and affiliated with University Hospital Brna, Michal Rezek, shares more.
COVID-19 in Czech Republic
Cases have been spiking as late due to a highly contagious variant filling up hospitals by the end of February. One of the hardest hit of European countries, lockdowns have followe...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).